DEHYDROCOSTUS LACTONE, (-)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C15H18O2
Molecular Weight	230.3022
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of DEHYDROCOSTUS LACTONE, (-)-

Structure Search

SMILES

[H][C@@]12CCC(=C)[C@]1([H])[C@@]3([H])OC(=O)C(=C)[C@]3([H])CCC2=C

InChI

InChIKey=NETSQGRTUNRXEO-XUXIUFHCSA-N

InChI=1S/C15H18O2/c1-8-4-7-12-10(3)15(16)17-14(12)13-9(2)5-6-11(8)13/h11-14H,1-7H2/t11-,12-,13-,14-/m0/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27545438
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25625870

Dehydrocostus lactone (DHL) is a sesquiterpene lactone originally found in species of Saussurea lappa C.B. Clarke (Compositae). DHL exhibits antibiotic, antioxidative, anti-angiogenic, anticancer chemotherapeutic, and chemopreventive activities. DHL inhibited cancer cell lines throughout PI3K/Akt Signaling Pathway, through inhibiting Wnt/β-catenin pathway. One of the latest investigation showed, that DHL inhibited the activity of cytosolic thioredoxin reductase (TrxR1) in HeLa cells, which elicited an accumulation of reactive oxygen species (ROS) in cells and a collapse of the intracellular redox equilibrium and eventually induced apoptosis of HeLa cells.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
PI3K-Akt signaling pathway 24 Target ID: map04151 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26017248	Inhibitor 8297
Thioredoxin reductase 1 2 Target ID: CHEMBL1927 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27545438	Inhibitor 8297

Conditions

Condition	Modality	Highest Phase	Product
Cervical cancer 40 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27545438	Primary	Basic research	Unknown Approved Use Unknown
Colorectal cancer 101 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25850883	Primary	Basic research	Unknown Approved Use Unknown
Prostate cancer 178 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18848968	Primary	Basic research	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Dehydrocostus lactone (DHC) inhibited human cervical carcinoma HeLa cells with an IC50 of ∼12.00 μM but displayed less cytotoxicity to human immortalized normal liver cells L02. DHC killed HeLa cells through induction of apoptosis. DHC inhibited the activity of TrxR1 in HeLa cells, which elicited an accumulation of reactive oxygen species (ROS) in cells and a collapse of the intracellular redox equilibrium and eventually induced apoptosis of HeLa cells.

Name

Type

Language

DEHYDROCOSTUS LACTONE, (-)-

Common Name

English

COSTUS LACTONE, DEHYDRO-

Common Name

English

DEHYDROCOSTUS LACTONE

Common Name

English

EPILIGULYL OXIDE

Common Name

English

(-)-DEHYDROCOSTUS LACTONE

Common Name

English

AZULENO(4,5-B)FURAN-2(3H)-ONE, DECAHYDRO-3,6,9-TRIS(METHYLENE)-, (3AS-(3A.ALPHA.,6A.ALPHA.,9A.ALPHA.,9B.BETA.))-

Common Name

English

AZULENO(4,5-B)FURAN-2(3H)-ONE, DECAHYDRO-3,6,9-TRIS(METHYLENE)-, (3AS,6AR,9AR,9BS)-

Common Name

English

GUAIA-4(15),10(14),11(13)-TRIEN-12-OIC ACID, 6.ALPHA.-HYDROXY-, .GAMMA.-LACTONE

Common Name

English

Code System Code Type Description

FDA UNII

71TRF5K040